trial seenhigh2026-10-19
null → {"status":"ACTIVE_NOT_RECRUITING","last_update_posted_at":"2026-10-19"}
📡 TrialPulse
Global clinical trial visibility
ACTIVE NOT RECRUITINGPHASE3
A Phase III, Randomized, Double-blind, Multi-center Trial Comparing Efficacy and Safety of Trilaciclib Versus Placebo in Participants With Limited-stage Small Cell Lung Cancer
NCT07881705·Jiangsu Simcere Pharmaceutical Co., Ltd.·source: ClinicalTrials.gov ↗·updated 2026-10-19
Registry history
Events detected for this trial — severity × confidence × recency
How to read the confidence score: 1.0 = observed — the registry record itself changed (a fact). <1.0 (e.g. 0.7) = signal — inferred by a heuristic rule from the data; it flags something worth a look, it is not a confirmed finding. Values below are shown raw from the database; the highlighted parts are the actual values, dimmed parts are JSON syntax.
Key dates
Start2026-06-17
Primary completion2027-07-15
Enrollment106actual
MyelosuppressionDRUGOTHERRADIATION
Site map
Per-site markers colored by site status
unknownShandong Cancer Hospital Affiliated to Shandong First Medical UniversityJinan, China